Editorials
Asthma mobile applications: Are they ready for prime time?

https://doi.org/10.1016/j.anai.2018.02.002Get rights and content

References (7)

There are more references available in the full text version of this article.

Cited by (6)

Disclosures: Dr Blaiss reported receiving support from PMD Healthcare, Pfizer, ALK, Stallergenes, Boston Scientific, JDP Therapeutics, and Sanofi/Regeneron.

View full text